Granisetron Hydrochloride
Overview
Granisetron Hydrochloride is a serotonin 5-HT3 receptor antagonist used primarily as an antiemetic to treat nausea and vomiting following chemotherapy. It works by blocking serotonin from binding to 5-HT3 receptors located on vagal nerve terminals and in the chemoreceptor trigger zone.
API suppliers (10)
Suppliers of Granisetron Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 8 of 10 suppliers.
6 of 10 hold a GMP certificate on record in the EU or UK registers
- WAVELENGTH ENTERPRISES LTDIsrael1 active DMF GMP on record
- Wockhardt UsaUnited Kingdom1 active DMF
- ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF GMP on record
- SCINOPHARM TAIWAN LTDTaiwan1 active DMF
- INKE SASpain1 active DMF
- Natco PharmaIndia1 active DMF GMP on record
- Amino Chemicals LtdMalta GMP on record
- Sun Pharmaceutical Industries LimitedIndia GMP on record
- MYLAN LABORATORIES LTD GMP on record
- HAMARI CHEMICALS LTD
Therapeutic areas
Do you supply Granisetron Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.